HCW Biologics Inc. (HCWB) Return on equity 2021–2025
HCW Biologics Inc. (HCWB) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-287.9%FY2025 · since FY2021: -25.1% → -287.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -287.9% | — |
| FY2023 | -185.7% | -145.9 pp |
| FY2022 | -39.8% | -14.7 pp |
| FY2021 | -25.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More HCWB financial trends
HCWB RevenueHCWB Net incomeHCWB Net marginHCWB Gross profitHCWB Gross marginHCWB Operating incomeHCWB Operating marginHCWB Operating cash flowHCWB Free cash flowHCWB Capital expendituresHCWB Stock buybacksHCWB Dividends paidHCWB Total assetsHCWB Total liabilitiesHCWB Shareholders’ equityHCWB overview →